RenovoRx Inc.

0.98
-0.02 (-1.99%)
At close: Feb 28, 2025, 3:59 PM
1.00
1.93%
After-hours: Feb 28, 2025, 04:00 PM EST

RenovoRx Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue n/a 6K 9K n/a n/a
Gross Profit n/a -6K -9K n/a n/a
Operating Income -11.4M -9.95M -5.67M -3.2M -3.9M
Interest Income n/a 57K n/a 3K 63K
Pretax Income -10.23M -9.89M -6.32M -3.8M -3.84M
Net Income -10.23M -9.77M -7.1M -4.38M -3.78M
Selling & General & Admin 5.73M 5.65M 2.63M 818K 899K
Research & Development 5.67M 4.3M 3.04M 2.39M 3M
Other Expenses n/a 61K 119K -7K 2K
Operating Expenses 11.4M 9.95M 5.67M 3.2M 3.9M
Interest Expense 108K 57K 834K 590K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 11.4M 9.95M 5.67M 3.2M 3.9M
Income Tax n/a -118K 772K 587K -63K
Shares Outstanding (Basic) 10.29M 9.05M 8.93M 8.66M 8.66M
Shares Outstanding (Diluted) 10.29M 9.05M 8.93M 8.66M 8.66M
EPS (Basic) -0.99 -1.08 -0.79 -0.51 -0.44
EPS (Diluted) -0.99 -1.08 -0.79 -0.51 -0.44
EBITDA -11.39M -9.94M -5.66M n/a n/a
Depreciation & Amortization 6K 6K 9K 3.2M 3.9M